Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [Contraception 2016; 93 (1): 25-31]
1 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA. Electronic address: jbalkus@fhcrc.org.
2 Vaccine and Infectious Disease Division, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
3 Department of Obstetrics, Gynecology and Reproductive Sciences and the Magee-Women's Research Institute, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
4 FHI360, Durham, NC, USA.
5 HIV Prevention Research Unit, South Africa Medical Research Council, Durban, South Africa.
6 University of Zimbabwe - University of California San Francisco Research Program, Harare, Zimbabwe.
7 College of Medicine, University of Malawi, Blantyre, Malawi.
8 Centre for Infectious Disease Research in Zambia, Lusaka, Zambia.
9 University of North Carolina Project, Kamuzu Central Hospital, Lilongwe, Malawi.
10 National Institutes of Health, Bethesda, MD, USA.
11 Centre for the AIDS Program of Research in South Africa, Doris Duke Medical Research Institute, Nelson R. Mandela School of Medicine, University of KwaZulu-Natal, Congella, South Africa; Department of Epidemiology, Mailman School of Public Health, Columbia University, New York, NY, USA.